Forbes Medi-Tech gets US patent for sterol extraction technology

Forbes Medi-Tech gets US patent for sterol extraction technology

Related tags Cholesterol Nutrition

The United States Patent and Trademark Office has granted a patent to Forbes Medi-Tech Corp. for technology to efficiently extract plant sterols and stanols from tall oil pitch.

US patent #8,338,564 “validates the many years of research and development by the dedicated team of scientists and engineers behind the development of our plant sterol-based technologies",​ said Laura Wessman, senior VP operations of Forbes, a division of Pharmachem Laboratories Inc. 

"This patent further strengthens our ability to broadly protect our proprietary technology as we develop heart healthy functional food and dietary supplement applications."

The company’s Reducol ingredient is derived from coniferous trees.

"In our research, overall findings indicate a 15.5% LDL-cholesterol reduction compared to the control group," ​added Wessman. "Low-fat diet alone accounted for 8.9% LDL-cholesterol reduction, hence a 'prudent' Western diet plus phytosterols brought about a decrease in total LDL cholesterol of 24.4% from baseline measurements."

Related topics R&D Health and wellness Ingredients

Related products

show more

What consumers are looking for in alcohol drinks

What consumers are looking for in alcohol drinks

Content provided by ADM | 12-Apr-2024 | Application Note

Are you ready to understand the consumer insights driving the future of the alcoholic beverage market? We've assembled a consumer insights report...

Redefine resilience with IMMUSE

Redefine resilience with IMMUSE

Content provided by Kyowa Hakko (US) | 02-Apr-2024 | White Paper

IMMUSETM is a universal postbiotic — the first of its kind to activate pDC cells for year-round immune support.

Related suppliers

Follow us

Products

View more

Webinars